Skip to content

Dr Birgit Kramer

Senior Associate


Kramer Birgit
Dr Birgit Kramer

Senior Associate


Birgit is a member of Allen & Overy's German IP practice, specialising in particular on patent law. She has long-standing experience in advising and representing clients, with a particular emphasis on the fields of pharmaceuticals and biotechnology, as well as consumer goods. 

Besides the representation of clients in complex court proceedings, her expertise primarily focuses on advising corporates on contract negotiations, for example on licence and R&D agreements. After completing her doctoral thesis at the Max Planck Institute for Intellectual Property she worked for law firms in Munich and Zurich, as well as with various major international companies.

News & insights

News: 13 DECEMBER 2019

Allen & Overy bolsters team with the appointment of arbitration Partner Anna Masser in Frankfurt

Allen & Overy continues to expand its German Dispute Resolution practice with the appointment of Anna Masser, who is due to join the firm's Frankfurt office as a partner on 1 February 2020. A respected international arbitration expert, she will head up Allen & Overy’s German Arbitration practice and will focus on international commercial arbitration in particular. She joins from Jones Day, where she was made partner at the beginning of the year.

Read more

Publications: 12 DECEMBER 2019

Allen & Overy publishes seventh edition of The Business and Human Rights Review

Allen & Overy’s Human Rights Working Group is pleased to announce the publication of the seventh edition of The Business and Human Rights Review.  

Read more

Publications: 11 DECEMBER 2019

Three practical tips to help brand owners protect their design rights

Read more

News: 10 DECEMBER 2019

Artificial intelligence is the most significant risk to businesses globally, according to directors

When asked about global risks affecting their businesses, nearly three fifths (58%) of directors stated that technological advances (artificial intelligence and machine learning) are the most significant threat. This is according to the seventh annual Directors’ Liability report by international law firm Allen & Overy, in conjunction with Willis Towers Watson (NASDAQ: WLTW), the global risk advisory and insurance broker.

Read more



Allen & Overy LLP
Maximilianstraße 35

View office →



Admitted as German Rechtsanwältin, Germany, 2005

Assessorin, Germany, 2002

Referendarin, Germany, 2000


Dr iur, Max Planck Institute for Intellectual Property/ Ludwig Maximilian University of Munich, Germany, 2005

Second German Law Degree, 2002

First German Law Degree, 2000

Published work

Kramer B., Feldges J. (2011) “Intellectual Property in the Life Sciences in Germany”, in: "Intellectual Property in the Life Sciences, A Global Guide to Rights and Their Applications", ed. Paul England

Kramer B., Feldges J. (2010) „Die Bestimmung des Schutzbereiches von ergänzenden Schutzzertifikaten für Arzneimittel“, in: Festschrift für Wolfgang von Meibom, Hrsg. Christian Harmsen, Oliver Jan Jüngst und Felix Rödiger

Kramer B., Feldges J. (2009) “Patent Law in Germany”, in: Business Laws of Germany, ed. Thomas Wegerich

Kramer B. (2007) „Patentschutz und Zugang zu Medikamenten, Rechtliche und ökonomische Implikation“, Köln: Heymanns Verlag